Vikas Goyal is a Partner, Growth Investments at Longwood Fund, where he focuses on biotech and therapeutics growth investments across biotechnology, life sciences, therapeutics, and healthcare. He invests across early and growth stages, including late preclinical and clinical stages (Series A–Series C), primarily in the United States, with emphasis on the Greater Boston and East Coast regions. Longwood Fund raised $180M in May 2023. He serves on the boards of Morphic Therapeutic, Nimbus Therapeutics, Zikani Therapeutics, CalciMedica, and Spero Therapeutics, and has invested in Pandion Therapeutics, Morphic Therapeutic, Nimbus Therapeutics, CalciMedica, and Spero Therapeutics. Before Longwood Fund, he was Managing Partner and Co‑Founder at Trekk Venture Partners, SVP Business Development at Pandion Therapeutics (including Merck integration), a Principal at SR One, and Manager, Corporate Strategy & Development at Infinity Pharmaceuticals. He studied at Harvard University and The Wharton School, University of Pennsylvania, and lives in Cambridge, Massachusetts.
Vikas Goyal, Partner @ Longwood. Profile with intro opportunities and ranking information.
Not Yet Mapped
We've created a profile for Vikas Goyal from Longwood Fund. Our ranking analysis and additional data will be available once our research is complete.
Rankings and detailed information coming soon
Network Strength
No ranking data available yet.
How to get an intro to Vikas
Map your path to Vikas instantly
Connect your network and Draftboard will automatically find and score the strongest paths to Vikas
That's it. Draftboard does the rest.
Rankings based on connection strength analysis - we ONLY show aggregate data, never specific connection data.